Accelerate Diagnostics
$10.019876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.28 (-2.72%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell AXDX and other stocks, options, and ETFs commission-free!
About AXDX
Accelerate Diagnostics, Inc. Common Stock, also called Accelerate Diagnostics, is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ. The listed name for AXDX is Accelerate Diagnostics, Inc. Common Stock.
CEO
Jack Phillips
Employees
275
Headquarters
Tucson, Arizona
Founded
1982
Market Cap
645.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
346.72K
High Today
$10.59
Low Today
$9.82
Open Price
$10.23
Volume
245.20K
52 Week High
$19.11
52 Week Low
$4.53
AXDX Earnings
-$0.40
-$0.37
-$0.35
-$0.32
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.32 per share
Actual
-$0.33 per share